SCHEMBL8123003

SCHEMBL8123003

COC(=O)Cc1nc(-c2ccc(OC)c(OC)c2)c2cc(Cl)ccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ CA12 O43570 3/20 0.46
▸ CA1 P00915 3/20 0.46
▸ CA2 P00918 3/20 0.46
▸ CA9 Q16790 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ MAT2A P31153 1/20 0.44
▸ AMY1A P0DUB6 1/20 0.43
▸ PLA2G2A P14555 1/20 0.43
▸ TP53 P04637 2/20 0.42
▸ THRB P10828 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ DHODH Q02127 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7818387 0.88 MAPT (0.46) HSD17B10KDM4ELMNAGAAMAPT
SCHEMBL8123477 0.85 MAT2A (0.57) MAPK1KDM4ELMNAGAAMAPT
SCHEMBL1879632 0.77 DHFR (0.54) CA12CA1CA2CA9GAA
SCHEMBL1879036 0.77 HSP90AB1 (0.65) TSHRMAPK1CASP1HSD17B10CA12
SCHEMBL9181338 0.75 SLC10A2 (0.47) MAPK1HSD17B10KDM4ELMNAGAA
SCHEMBL1878969 0.72 DHFR (0.54) TSHRMAPK1CASP1HSD17B10CA12
SCHEMBL24108945 0.72 POLB (0.56) MAPK1KDM4ELMNAGAAMAPT
SCHEMBL26314747 0.72 KDM4E (0.55) MAPK1CASP1KDM4ELMNAGAA
SCHEMBL12639862 0.72 HSP90AB1 (0.58) CA12CA1CA2CA9GAA
SCHEMBL1872485 0.72 DHFR (0.54) TSHRMAPK1CASP1HSD17B10CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0634169-B1 Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2000-01-05 — — EP disclosed
US-5852039-A Pharmaceutical composition containing quinoline or quinazoline derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-12-22 — — US disclosed
US-5719157-A OSTEOPOROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-02-17 — — US disclosed
EP-0634169-A1 Pharmaceutical composition containing quinoline or quinazoline derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-01-18 — — EP disclosed
Send feedback